- Home
- COMM vs APLT Comparison
COMM vs APLT Comparison
Compare COMM & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- APLT
- Stock Information
- Founded
- COMM 1976
- APLT 2016
- Country
- COMM United States
- APLT United States
- Employees
- COMM N/A
- APLT N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- COMM Technology
- APLT Health Care
- Exchange
- COMM Nasdaq
- APLT Nasdaq
- Market Cap
- COMM 1.3B
- APLT 44.0M
- IPO Year
- COMM 2013
- APLT 2019
- Fundamental
- Price
- COMM $7.53
- APLT $0.41
- Analyst Decision
- COMM Hold
- APLT Buy
- Analyst Count
- COMM 5
- APLT 7
- Target Price
- COMM $4.88
- APLT $6.10
- AVG Volume (30 Days)
- COMM 5.9M
- APLT 2.6M
- Earning Date
- COMM 08-07-2025
- APLT 08-06-2025
- Dividend Yield
- COMM N/A
- APLT N/A
- EPS Growth
- COMM N/A
- APLT N/A
- EPS
- COMM 3.42
- APLT N/A
- Revenue
- COMM $4,417,100,000.00
- APLT $265,000.00
- Revenue This Year
- COMM $21.50
- APLT $1,768.13
- Revenue Next Year
- COMM $8.30
- APLT $292.85
- P/E Ratio
- COMM $294.91
- APLT N/A
- Revenue Growth
- COMM 16.19
- APLT N/A
- 52 Week Low
- COMM $1.32
- APLT $0.30
- 52 Week High
- COMM $8.67
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- COMM 55.72
- APLT 58.87
- Support Level
- COMM $7.67
- APLT $0.32
- Resistance Level
- COMM $8.67
- APLT $0.36
- Average True Range (ATR)
- COMM 0.41
- APLT 0.04
- MACD
- COMM -0.07
- APLT 0.01
- Stochastic Oscillator
- COMM 55.29
- APLT 94.92
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.